LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) is sponsoring the inaugural Good Health: Mind, Body & Soul Summit, an invitation-only event scheduled for February 19 at Morehouse College in Atlanta. The Summit brings together leaders in health, culture, science, and community to advance health equity for Black men and families. The event is inspired by the music, legacy, and lived experiences of the hip-hop group De La Soul, specifically their song ‘Good Health,’ written following the passing of founding member David Jolicoeur.
Developed in collaboration with Blacksmith holdings, the program reflects De La Soul’s evolution from musical pioneers to wellness advocates. Discussions at the Summit will span critical health topics including cancer, heart disease, mental health, addiction, sleep, relationships, and intergenerational wellness. LIXTE stated that the Summit aligns with its mission as a clinical-stage pharmaceutical company advancing cancer care through its first-in-class oncology compound LB-100 and its European research subsidiary, LIORA. The company aims to create a space that connects scientific innovation with communities most impacted by health disparities.
LIXTE Biotechnology Holdings is focused on new targets for cancer drug development. The company has demonstrated that its lead clinical PP2A inhibitor, LB-100, is well-tolerated in cancer patients at doses associated with anti-cancer activity. Based on extensive published preclinical data available at https://www.lixte.com, LB-100 has the potential to significantly enhance chemotherapies and immunotherapies and improve outcomes for patients with cancer. LIXTE’s lead compound is part of a pioneering effort in an entirely new field of cancer biology known as activation lethality, which is advancing a new treatment paradigm covered by a comprehensive patent portfolio.
Proof-of-concept clinical trials for LB-100 are currently in progress for Ovarian Clear Cell Carcinoma and Metastatic Colon Cancer. The sponsorship of the Good Health Summit represents a strategic alignment of LIXTE’s scientific objectives with broader public health initiatives. By participating in community-focused events, the company seeks to bridge the gap between laboratory research and real-world health outcomes, particularly for populations facing significant health inequities. The latest news and updates relating to LIXT are available in the company’s newsroom at https://ibn.fm/LIXT.
This news story relied on content distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is LIXTE Biotechnology Sponsors Health Equity Summit at Morehouse College, Linking Cancer Research to Community Wellness.